Product Program year 2025 Source: CMS Open Payments

Nanocross Elite

Device Percutaneous Transluminal Angioplasty (PTA) Balloons

PDI 00763000109882

Open in the dashboard

General payments

$5,578

310 payments

Research payments

$41,565

4 payments

Through program year 2025, $5,578 in general payments and $41,565 in research payments were reported against Nanocross Elite (Percutaneous Transluminal Angioplasty (PTA) Balloons).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $2,330 114
2025 Research $41,565 4
2024 General $1,029 57
2023 General $1,073 70
2022 General $1,146 69

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $5,578 310 payments
Top recipients General payments · program year 2025
  1. Polyxene Kokinos Campbell, CA $99 4% · 1 payment
  2. Ruby Lo Vascular Surgery · Campbell, CA $99 4% · 1 payment
  3. Ryan Gupta Vascular Surgery · Campbell, CA $99 4% · 1 payment
  4. Alma Acosta Nurse Practitioner, Acute Care · El Paso, TX $96 4% · 5 payments
  5. Mohammad Raja Interventional Cardiology · El Paso, TX $96 4% · 5 payments

The top 5 of 62 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $882 40% · 23 practitioners
  2. Interventional Cardiology Internal Medicine $330 15% · 11 practitioners
  3. Cardiovascular Disease Internal Medicine $314 14% · 8 practitioners
  4. Nurse Practitioner, Acute Care Nurse Practitioner $247 11% · 3 practitioners
  5. Vascular & Interventional Radiology Radiology $117 5% · 4 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $706 30% · 14 recipients
  2. California $600 26% · 13 recipients
  3. New York $395 17% · 13 recipients
  4. Arizona $156 7% · 3 recipients
  5. New Mexico $138 6% · 8 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

310 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record